What is Dna Group (T.R.) Ltd (DNA.TA)?

Dna Group (T.R.) Ltd (DNA.TA) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Dna Group (T.R.) Ltd (DNA.TA)

Stock analysis · TLV · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.01

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Dna Group (T.R.) Ltd (DNA.TA) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Dna Group (T.R.) Ltd

Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of proprietary ultrasound technologies. These advanced systems are utilized to evaluate bone strength and density, as well as to detect and monitor calcium leakage associated with osteoporosis in both adult and pediatric patients. The company's offerings are employed by trained physicians, nurses, and operators within hospitals, clinics, pharmacies, and various other healthcare environments across Israel, North America, East Asia, and international markets. Beyond its core ultrasound business, the group is also involved in the creation of oral medications. Established in 2004 and based in Tel Aviv-Yafo, Israel, the company was formerly known as D.N.A Biomedical Solutions Ltd. before adopting its current name in November 2022.